AltAssets is the private equity news and research service from Almeida Capital
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

Biotechnology investment opportunities in New Zealand

27/11/2001Source: Investment New Zealand.  

New Zealand's biotech industry is thriving and its government is committed to accelerating the development of a knowledge-based economy. This article from Investment New Zealand offers an overview for investors who want to take advantage of the biotech investment opportunities that this region can offer.

Opportunities for investors should continue to grow as a result of government initiatives, such as the establishment of a US$40m venture investment fund for the development of the high-tech and biotech sectors. A favourable regulatory environment and a strong life sciences research base add to the attraction of New Zealand as a focus for biotech investment.  

Click here to view full report (pdf 355kb)

Copyright © 2001 Investment New Zealand (of the New Zealand Trade Development Board)

For more information on Trade and Investment in New Zealand, please visit www.tradenz.govt.nz

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter